Search Results

342,238 Results for "arcutis pharmaceuticals acquired by valeant pharmaceuticals".

Sort By

Press Releases

Jabil Acquires Pharmaceutics International, Inc. (Pii)

February 4, 2025
·
4 min read
Press Releases

Arcutis to Present at the Guggenheim SMID Cap Biotech Conference

January 27, 2025
·
2 min read
Press Releases

Arcutis to Present at the TD Cowen 45th Annual Health Care Conference

February 18, 2025
·
2 min read
Press Releases

Arcutis to Present Two Posters at the 83rd American Academy of Dermatology Annual Meeting

February 28, 2025
·
7 min read
Press Releases

Arcutis Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

February 25, 2025
·
12 min read
Press Releases

Arcutis Announces Promotions on Executive Management Team

December 3, 2024
·
5 min read
Press Releases

Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.

December 30, 2024
·
11 min read
Press Releases

Arcutis Announces ZORYVE® U.S. Co-promote Agreement with Kowa Pharmaceuticals America, Inc.

July 29, 2024
·
7 min read
Press Releases

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 5, 2025

February 6, 2025
·
3 min read
Deals

Cycle Pharmaceuticals Announces All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share

Cycle Pharmaceuticals Ltd today confirmed that it made a proposal to the Board of Directors of Vanda Pharmaceuticals, Inc. (“Vanda”) (NASDAQ: VNDA) on May 24, 2024 to acquire 100% of Vanda’s issued and outstanding shares for a cash consideration of $8.00 per Vanda share, representing a total cash consideration of $466 million.

June 6, 2024
·
5 min read